Assessment of psychosocial well-being, psychological distress, and financial burden in patients with chronic and recurrent dermatophytosis.

Chronic dermatophytosis, a persistent fungal infection lasting over six months, is a significant public health concern. The study examines the psychosocial well-being, psychological distress, and financial burden experienced by patients with chronic and recurrent dermatophytosis. A hospital-based cross-sectional design was employed, enrolling 316 patients from a tertiary care dermatology outpatient department in South India over six months. Participants completed questionnaires of quality of life (Dermatology Life Quality Index, DLQI), financial burden (Financial Burden and Worry questionnaire, FBW), and psychological distress (Hospital Anxiety and Depression Scale, HADS). Findings revealed a substantial impact on the quality of life, with 71.6% of participants reporting a very large effect as per DLQI scores. Factors such as itching, embarrassment, and daily routine disturbances were significantly associated with higher DLQI scores. Financial challenges were prominent, with 56.6% of participants delaying treatment due to financial constraints and 30.7% reducing overall expenses. The economic burden was further evident as 26.2% used savings, 12.9% borrowed money, and 16.1% reduced essential healthcare spending for other family members. Psychological distress was significant, with 31.6% and 29.7% of participants showing abnormal anxiety and depression scores, respectively, on HADS. A strong positive correlation was observed between DLQI scores, anxiety, and depression, highlighting the interdependence between disease severity and mental health. This study underscores the need for a holistic approach to managing chronic dermatophytosis, addressing not only medical but also psychosocial and financial aspects. Integrating affordable treatment options, public health awareness campaigns, and psychological counselling can significantly alleviate the burden on affected individuals. These findings provide critical insights for clinicians and policymakers to design comprehensive care strategies aimed at improving patient outcomes and quality of life.